Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
vTv Therapeutics Inc. (VTVT)
:VTVT
Holding VTVT?
Track your performance easily
VTVT Stock Chart & Stats
Day’s Range― - ―
52-Week Range$7.38 - $30.99
Previous CloseN/A
Volume611.00
Average Volume (3M)16.39K
Market Cap
$44.80M
Enterprise Value$35.56M
Total Cash (Recent Filing)$51.51M
Total Debt (Recent Filing)$11.06M
Price to Earnings (P/E)―
Beta0.62
Next Earnings
Feb 20, 2025EPS Estimate
-0.87Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-4.53
Shares Outstanding2,612,257
10 Day Avg. Volume9,522
30 Day Avg. Volume16,389
Standard Deviation0.24
R-Squared0.02
Alpha-0.00946
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)44.80
Price to Cash Flow (P/CF)-1.80
P/FCF Ratio0.00
Enterprise Value/Market Cap0.79
Enterprise Value/Revenue35.56
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda-1.59
Forecast
1Y Price Target
$35.00Price Target Upside149.11% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
vTv Therapeutics News
PremiumCompany Announcements
vTv Therapeutics Highlights Progress on Diabetes Treatment
PremiumCompany Announcements
vTv Therapeutics Faces License Agreement Termination
Ownership Overview
19.44% Insiders
1.93% Mutual Funds
11.68% Other Institutional Investors
65.24% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
VTVT FAQ
What was vTv Therapeutics Inc.’s price range in the past 12 months?
vTv Therapeutics Inc. lowest stock price was $7.38 and its highest was $30.99 in the past 12 months.
What is vTv Therapeutics Inc.’s market cap?
vTv Therapeutics Inc.’s market cap is $44.80M.
When is vTv Therapeutics Inc.’s upcoming earnings report date?
vTv Therapeutics Inc.’s upcoming earnings report date is Feb 20, 2025 which is in 30 days.
How were vTv Therapeutics Inc.’s earnings last quarter?
vTv Therapeutics Inc. released its earnings results on Nov 12, 2024. The company reported -$0.88 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.88.
Is vTv Therapeutics Inc. overvalued?
According to Wall Street analysts vTv Therapeutics Inc.’s price is currently Undervalued.
Does vTv Therapeutics Inc. pay dividends?
vTv Therapeutics Inc. does not currently pay dividends.
What is vTv Therapeutics Inc.’s EPS estimate?
vTv Therapeutics Inc.’s EPS estimate is -0.87.
How many shares outstanding does vTv Therapeutics Inc. have?
vTv Therapeutics Inc. has 2,612,257 shares outstanding.
What happened to vTv Therapeutics Inc.’s price movement after its last earnings report?
vTv Therapeutics Inc. reported an EPS of -$0.88 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 7.117%.
Which hedge fund is a major shareholder of vTv Therapeutics Inc.?
Currently, no hedge funds are holding shares in VTVT
---
vTv Therapeutics Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$35.00 (149.11% Upside)
$35.00 (149.11% Upside)
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.7%
Last 30 Days ▲ 14.4%
Last 30 Days ▲ 14.4%
Technicals
SMA
Negative
20 days / 200 days
Momentum
62.12%
12-Months-Change
Fundamentals
Return on Equity
-121.97%
Trailing 12-Months
Asset Growth
189.23%
Trailing 12-Months
Company Description
vTv Therapeutics Inc.
vTv Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. Its products target the treatment of central nervous system disorders, diabetes and metabolic disorders, inflammation, and cancer. It offers Azeliragon, TTP399, TTP273, HPP593, HPP737, and Nrf2/Bach1 program. The company was founded on April 2, 2015 and is headquartered in High Point, NC.
---
VTVT Stock 12 Month Forecast
Average Price Target
$35.00
▲(149.11% Upside)
Technical Analysis
Aclaris Therapeutics
―
Corbus Pharmaceuticals
―
Medicinova
―
Oragenics
―
Pulmatrix
―
GlycoMimetics
―
Best Analysts Covering VTVT
1 Year
1 Year Success Rate
0/1 ratings generated profit
1 Year Average Return
-23.40%
initiated a buy rating last month
Copying James Molloy's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -23.40% per trade.
---